Naticol® x3Peptide
Naticol® x3 Peptide is advanced marine collagen types I and III from Weishardt, the first European manufacturer of collagen tripeptides. It is a highly bioactive collagen that contains at least 25% of tripeptides, which significantly distinguishes it from classical collagen peptides.
1. Composition and Technology allows: 2. Quality and origin
[[t777]
1. Skin - Clinically proven results (2.5g/day, 8 weeks)
- –42% number of wrinkles [[t130]–24% length wrinkles
- –21% wrinkle surface
- +31% skin brightness
- +34 % glow
- +12% hydration
- +13% skin lightening [[t388]
Confirmed in a clinical study on 45 women (55-70 years old). 2. Joints and mobility joints
In vitro tests:
- [[t656]–27% MMP9 (cartilage degrading enzyme)[[t725]–37 % IL‑1β (inflammatory marker)
- +46% TGF‑β (skin regeneration) [[t835]+12% faster healing wound
3. Sports regeneration (5 g/day, 3 months)Consumer panel (34 people) reports:
- 68% faster regeneration [[t1052]85 % less joint pain
- 77% less muscle pain
- 74% less muscle pain tendons
- 59% better mobility
- significantly more tripeptides (≥25% vs. 1-5% in conventional collagens),
- lower molecular weight → faster absorption,
- higher bioactivity → better results at the same dose,
- clinically proven effects on skin, joints and regeneration.
Naticol® x3 Peptide represents a new generation of collagen which, due to its high tripeptide content, extremely low molecular weight and clinically proven effects, offers significantly better results than standard collagen peptides. It is suitable for premium nutritional supplements, functional drinks and sports nutrition.
In which Elixiré product is Naticol® x3Peptide? found
Legal notice|
Naticol® x3Peptide, an ingredient marketed by Weishardt, is intended for inclusion in food products or nutritional supplements by specialty companies. As such, the information provided on this page is intended specifically for them. In accordance with the requirements of the European Directive 2006/114/EC, Weishardt guarantees the veracity of the information regarding the beneficial effects of Naticol® x3Peptide on health when used under the conditions in which it was tested. However, this in no way excuses those who market foods and nutritional supplements containing Naticol® x3Peptide from verifying the veracity of these claims when they are used in their products. In addition, European Regulation 1924/2006/EC regulates the use of nutrition and health claims on foods intended for the final consumer. Claims related to the health benefits of Naticol® x3Peptide, as mentioned on this page, are therefore not covered by the requirements of this regulation. This information has not been evaluated by the Food and Medicines Agency and therefore does not constitute health claims endorsed by EFSA.